purine nucleoside phosphorylase inhibitors (Merrell Dow)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namepurine nucleoside phosphorylase inhibitors (Merrell Dow)
Drug Alias NamePNP inhibitors (Merrell Dow)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsRejection of organ transplantationGoutLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerrell Dow Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerrell Dow Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationGoutLymphoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A